File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Two-Year Clinical Results After Selective Laser Trabeculoplasty for Normal Tension Glaucoma

TitleTwo-Year Clinical Results After Selective Laser Trabeculoplasty for Normal Tension Glaucoma
Authors
Issue Date2015
PublisherLippincott Williams & Wilkins.
Citation
Medicine (Baltimore): analytical reviews of general medicine, neurology, psychiatry, dermatology and pediatrics, 2015, v. 94 n. 24, p. e984 How to Cite?
AbstractThis article aims to investigate the clinical results at 2 years after selective laser trabeculoplasty (SLT) for normal tension glaucoma (NTG). This prospective cohort study recruited NTG patients taking antiglaucoma medication. Subjects were excluded if they had previous glaucoma surgery/laser or corneal pathologies. All subjects underwent a 1-month washout. A single session of SLT was performed to 360° of the trabecular meshwork. Medication was resumed at 1 month to achieve a targeted 30% intraocular pressure (IOP) reduction from the post-washout/pre-SLT IOP. IOP was measured every 3 months and medication use was recorded at 3, 6, 12, and 24 months. Subjects with a secondary SLT or cataract extraction were excluded from IOP and medication analyses. At 24 months, 34 of the initial 45 right eyes were eligible for analyses. There were significant IOP reductions at all time intervals (except at 1 week) following SLT when compared to the prestudy (without medication) or pre-SLT (post-washout) IOP (P < 0.0001). Medications were likewise significantly reduced at all time intervals following SLT (P < 0.0001). At 24 months, the IOP was 11.5% lower than the prestudy IOP, 22.0% lower than the pre-SLT IOP, and medication use was reduced by 41.1% (P < 0.0001). Six out of 45 eyes (13.3%) required a secondary SLT. Absolute success (IOP reduction >20% from pre-SLT, without medication) was achieved in 11.1% (5/45). Reductions in IOP and medication use were evident at 2 years following SLT for the treatment of NTG whereas 11% remained medication free. Trial Registrations: The Clinical Trials Register of the University of Hong Kong HKCTR1847. The European Clinical Trials Database 2014-003305-15 (August 11, 2014).
DescriptionOpen Access Journal
Persistent Identifierhttp://hdl.handle.net/10722/212537
ISSN
2015 Impact Factor: 1.206
2015 SCImago Journal Rankings: 0.877
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLee, JWY-
dc.contributor.authorShum, JWH-
dc.contributor.authorChan, JCH-
dc.contributor.authorLai, JSM-
dc.date.accessioned2015-07-21T02:39:52Z-
dc.date.available2015-07-21T02:39:52Z-
dc.date.issued2015-
dc.identifier.citationMedicine (Baltimore): analytical reviews of general medicine, neurology, psychiatry, dermatology and pediatrics, 2015, v. 94 n. 24, p. e984-
dc.identifier.issn0025-7974-
dc.identifier.urihttp://hdl.handle.net/10722/212537-
dc.descriptionOpen Access Journal-
dc.description.abstractThis article aims to investigate the clinical results at 2 years after selective laser trabeculoplasty (SLT) for normal tension glaucoma (NTG). This prospective cohort study recruited NTG patients taking antiglaucoma medication. Subjects were excluded if they had previous glaucoma surgery/laser or corneal pathologies. All subjects underwent a 1-month washout. A single session of SLT was performed to 360° of the trabecular meshwork. Medication was resumed at 1 month to achieve a targeted 30% intraocular pressure (IOP) reduction from the post-washout/pre-SLT IOP. IOP was measured every 3 months and medication use was recorded at 3, 6, 12, and 24 months. Subjects with a secondary SLT or cataract extraction were excluded from IOP and medication analyses. At 24 months, 34 of the initial 45 right eyes were eligible for analyses. There were significant IOP reductions at all time intervals (except at 1 week) following SLT when compared to the prestudy (without medication) or pre-SLT (post-washout) IOP (P < 0.0001). Medications were likewise significantly reduced at all time intervals following SLT (P < 0.0001). At 24 months, the IOP was 11.5% lower than the prestudy IOP, 22.0% lower than the pre-SLT IOP, and medication use was reduced by 41.1% (P < 0.0001). Six out of 45 eyes (13.3%) required a secondary SLT. Absolute success (IOP reduction >20% from pre-SLT, without medication) was achieved in 11.1% (5/45). Reductions in IOP and medication use were evident at 2 years following SLT for the treatment of NTG whereas 11% remained medication free. Trial Registrations: The Clinical Trials Register of the University of Hong Kong HKCTR1847. The European Clinical Trials Database 2014-003305-15 (August 11, 2014).-
dc.languageeng-
dc.publisherLippincott Williams & Wilkins.-
dc.relation.ispartofMedicine (Baltimore): analytical reviews of general medicine, neurology, psychiatry, dermatology and pediatrics-
dc.rightsThis is a non-final version of an article published in final form in (provide complete journal citation)-
dc.titleTwo-Year Clinical Results After Selective Laser Trabeculoplasty for Normal Tension Glaucoma-
dc.typeArticle-
dc.identifier.emailLee, JWY: jackylee@hku.hk-
dc.identifier.emailShum, JWH: jenni101@hku.hk-
dc.identifier.emailChan, JCH: jonochan@hkucc.hku.hk-
dc.identifier.emailLai, JSM: laism@hku.hk-
dc.identifier.authorityLee, JWY=rp01498-
dc.identifier.authorityShum, JWH=rp01849-
dc.identifier.authorityChan, JCH=rp02113-
dc.identifier.authorityLai, JSM=rp00295-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1097/MD.0000000000000984-
dc.identifier.pmid26091474-
dc.identifier.scopuseid_2-s2.0-84941365312-
dc.identifier.hkuros244319-
dc.identifier.hkuros264618-
dc.identifier.volume94-
dc.identifier.issue24-
dc.identifier.spagee984-
dc.identifier.epagee984-
dc.identifier.isiWOS:000360804900001-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats